Literature DB >> 14165884

TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.

M L ORIGENES, E C BEATTY, C BRUBAKER, D HAMMOND, J R HARTMANN, N SHORE, K O WILLIAMS.   

Abstract

Entities:  

Keywords:  ACTINOMYCIN; ANTINEOPLASTIC AGENTS; BUSULFAN; CHILD; CYCLOPHOSPHAMIDE; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; MERCAPTOPURINE; NEUROBLASTOMA; SARCOMA; SARCOMA, RETICULUM CELL; UREA

Mesh：

Substances：

Year:  1964        PMID： 14165884

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

Review 1.  Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Authors:  Xiangyi Lu; Li Xiao; Luan Wang; Douglas M Ruden
Journal:  Biochem Pharmacol       Date:  2011-11-22       Impact factor: 5.858

2.  Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study.

Authors:  Ronald Dubowy; Michael Graham; Nasrollah Hakami; Morris Kletzel; Donald Mahoney; Edward Newman; Yaddanapudi Ravindranath; Bruce Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2008-05       Impact factor: 1.289
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.